
Galapagos NV GLPG
$ 32.85
-1.58%
Annual report 2024
added 02-28-2026
Galapagos NV DPO Ratio 2011-2026 | GLPG
Annual DPO Ratio Galapagos NV
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | - | - | - | - | 81.9 | 98.6 | 260 | 167 | - |
All numbers in EUR currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 260 | 81.9 | 152 |
DPO Ratio of other stocks in the Biotechnology industry
| Issuer | DPO Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Acorda Therapeutics
ACOR
|
277 | - | -24.86 % | $ 820 K | ||
|
I-Mab
IMAB
|
2.24 K | - | - | $ 866 M | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
78.2 | - | - | $ 40.3 B | ||
|
ADMA Biologics
ADMA
|
35.9 | $ 15.36 | -2.17 % | $ 3.66 B | ||
|
Cellectis S.A.
CLLS
|
975 | $ 3.53 | -3.54 % | $ 116 M | ||
|
AgeX Therapeutics
AGE
|
9.04 K | - | -10.17 % | $ 12.2 K | ||
|
Midatech Pharma plc
MTP
|
162 | - | -18.52 % | $ 27.3 M | ||
|
Nymox Pharmaceutical Corporation
NYMX
|
2.41 K | - | -19.68 % | $ 18.4 M | ||
|
Aptorum Group Limited
APM
|
405 | $ 0.79 | -1.15 % | $ 4.31 M | ||
|
China SXT Pharmaceuticals
SXTC
|
324 | $ 2.01 | -1.36 % | $ 2.86 M | ||
|
Ampio Pharmaceuticals
AMPE
|
2.85 K | - | -11.43 % | $ 502 K | ||
|
Институт стволовых клеток человека
ISKJ
|
115 | - | - | - | ||
|
Anika Therapeutics
ANIK
|
54.4 | $ 14.05 | -1.44 % | $ 206 M | ||
|
ANI Pharmaceuticals
ANIP
|
60.1 | $ 74.36 | -1.64 % | $ 1.44 B | ||
|
AVEO Pharmaceuticals
AVEO
|
235 | - | - | $ 521 M | ||
|
Axsome Therapeutics
AXSM
|
529 | $ 162.43 | 0.6 % | $ 8.08 B | ||
|
BioCryst Pharmaceuticals
BCRX
|
484 | $ 8.49 | -0.18 % | $ 1.75 B | ||
|
BridgeBio Pharma
BBIO
|
399 | $ 65.66 | -0.78 % | $ 12.6 B | ||
|
Acasti Pharma
ACST
|
4.39 K | - | 4.01 % | $ 150 M | ||
|
BioDelivery Sciences International
BDSI
|
96.3 | - | -4.8 % | $ 255 M | ||
|
BeiGene, Ltd.
BGNE
|
915 | - | 0.49 % | $ 251 B | ||
|
Berkeley Lights
BLI
|
135 | - | -7.31 % | $ 87 M | ||
|
Aeterna Zentaris
AEZS
|
34.4 K | - | 5.93 % | $ 314 M | ||
|
BioMarin Pharmaceutical
BMRN
|
245 | $ 61.3 | 1.21 % | $ 11.8 B |